Real-world data in the United Kingdom: opportunities and challenges

被引:27
作者
McDonald, Laura [1 ]
Lambrelli, Dimitra [1 ]
Wasiak, Radek [1 ]
Ramagopalan, Sreeram V. [1 ]
机构
[1] Evidera, Metro Bldg,6th Floor,1 Butterwick, London W6 8DL, England
来源
BMC MEDICINE | 2016年 / 14卷
关键词
Real-world evidence; Care.data; United Kingdom; MEDICAL-RESEARCH; OPT-OUT; REGISTRY; CONSENT; TRIAL;
D O I
10.1186/s12916-016-0647-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Real-world data is that collected outside the constraints of controlled clinical trials and is increasingly informing decision-making in healthcare. The landscape of real-world data in the United Kingdom is set to evolve over the coming months as the government plans to build on databases currently in place by collecting patient data from all family practices and linking this information with hospital records. This initiative, called care. data, has the potential to be an invaluable resource. However, the programme has been criticized on grounds of data privacy, which has led to an extended delay in its implementation and the expectation that a large number of people will opt out. Opt-outs may introduce substantial biases to the dataset, and understanding how to account for these presents a significant challenge for researchers. For the scope and quality of real-world evidence in the United Kingdom to be realised, and for this information to be used effectively, it is essential to address this challenge.
引用
收藏
页数:3
相关论文
共 50 条
  • [41] The use of real-world data/evidence in regulatory submissions
    Song, Fuyu
    Zang, Chenxuan
    Ma, Xinyi
    Hu, Sifan
    Sun, Qiqing
    Chow, Shein-Chung
    Sun, Hongqiang
    CONTEMPORARY CLINICAL TRIALS, 2021, 109
  • [42] Clinical Pharmacology Applications of Real-World Data and Real-World Evidence in Drug Development and Approval-An Industry Perspective
    Zhu, Rui
    Vora, Bianca
    Menon, Sujatha
    Younis, Islam
    Dwivedi, Gaurav
    Meng, Zhaoling
    Datta-Mannan, Amita
    Manchandani, Pooja
    Nayak, Satyaprakash K.
    Tammara, Brinda
    Garhyan, Parag
    Iqbal, Shahed
    Dagenais, Simon
    Chanu, Pascal
    Mukherjee, Arnab
    Ghobadi, Cyrus
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (04) : 751 - 767
  • [43] Report on the current status of the use of real-world data (RWD) and real-world evidence (RWE) in drug development and regulation
    Breckenridge, Alasdair M.
    Breckenridge, Ross A.
    Peck, Carl C.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (09) : 1874 - 1877
  • [44] Real-world evidence of allergen immunotherapy
    Buta, Federica
    Paoletti, Giovanni
    Bragato, Maria Chiara
    Giovannini, Mattia
    Canonica, Giorgio Walter
    Heffler, Enrico
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 24 (06) : 529 - 535
  • [45] Real-world treatment patterns and outcomes in non-transplant newly diagnosed multiple Myeloma in France, Germany, Italy, and the United Kingdom
    Mohty, Mohamad
    Knauf, Wolfgang
    Romanus, Dorothy
    Corman, Shelby
    Verleger, Katharina
    Kwon, Youngmin
    Cherepanov, Dasha
    Cambron-Mellott, M. Janelle
    Vikis, Haris G.
    Gonzalez, Francisco
    Gavini, Francois
    Ramasamy, Karthik
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (03) : 308 - 325
  • [46] Real-world evidence of epidemiology, patient characteristics, and mortality in people with drug-resistant epilepsy in the United Kingdom, 2011-2021
    Shankar, Rohit
    Marston, Xiaocong Li
    Danielson, Vanessa
    Do Rego, Bronwyn
    Lasagne, Reginald
    Williams, Oliver
    Groves, Lara
    JOURNAL OF NEUROLOGY, 2024, 271 (05) : 2473 - 2483
  • [47] Real-world evidence: experiences and challenges for decision making in Latin America
    Garcia Marti, Sebastian
    Pichon-Riviere, Andres
    Augustovski, Federico
    Espinoza, Manuel
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2023, 39 (01)
  • [48] How to Deal with the Inevitable: Generating Real-World Data and Using Real-World Evidence for HTA Purposes - From Theory to Action
    Oortwijn, Wija
    Sampietro-Colom, Laura
    Trowman, Rebecca
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2019, 35 (04) : 346 - 350
  • [49] New opportunities of real-world data from clinical routine settings in life-cycle management of drugs: example of an integrative approach in multiple sclerosis
    Rothenbacher, Dietrich
    Capkun, Gorana
    Uenal, Hatice
    Tumani, Hayrettin
    Geissbuhler, Yvonne
    Tilson, Hugh
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (05) : 953 - 965
  • [50] Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database
    Philip J. Mease
    Pamela Young
    David Gruben
    Lara Fallon
    Rebecca Germino
    Arthur Kavanaugh
    Advances in Therapy, 2022, 39 : 2932 - 2945